• BIOATLA APPOINTS EDWARD L. WILLIAMS TO BOARD OF DIRECTORS

    28 days ago - By San Diego Biotechnology

    SAN DIEGO: SAN DIEGO, Dec. 21, 2021 /PRNewswire/ - BioAtla, Inc., a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic antibody therapeutics, today announced that Edward L. Williams has been appointed to the BioAtla Board of Directors and has agreed to serve on the...
    Read more ...